Analysis of Injury Risk Factors in Elite Athletes
Launched by UNIVERSITY OF OVIEDO · Mar 25, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the risk factors for tendon injuries in professional middle- and long-distance athletes. The study aims to identify what specific aspects, like age, training routines, types of shoes, and diet, might influence the chances of these athletes getting injured. By examining these factors, researchers hope to develop better strategies to prevent injuries and keep athletes healthy.
To participate in this study, athletes must be elite competitors who have not had any major surgeries related to their muscles or bones in the past few years and have been competing for at least one year prior to the study. Participants will provide information about their training, diet, and injury history, helping researchers understand how these elements contribute to tendon injuries. This research is important because it could lead to better injury prevention methods, allowing athletes to train and compete more safely.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Elite federated athletes
- • Who have not undergone previous musculoskeletal surgery in the seasons under study
- • Who were federated at least one year before the study period
- • Sign the informed consent document.
- Exclusion Criteria:
- • Athletes who have not participated in competition, during the study seasons, for a period of more than 6 months due to a musculoskeletal injury
About University Of Oviedo
The University of Oviedo is a renowned academic institution located in Spain, committed to advancing research and innovation in various fields, including healthcare and clinical studies. With a focus on fostering scientific excellence, the university collaborates with multidisciplinary teams to conduct cutting-edge clinical trials that aim to improve patient outcomes and contribute to medical knowledge. The institution is dedicated to adhering to the highest ethical standards and regulatory requirements, ensuring the integrity and reliability of its research efforts while promoting the translation of findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oviedo, Asturias, Spain
Patients applied
Trial Officials
Rubén Cuesta-Barriuso
Study Director
Universidad de Oviedo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported